Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06544109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Study acronym: Ven APL
StatusEnrolling by Invitation
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 9, 2024 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study is to assess the efficacy and safety of venetoclax for prevention of DS in APL patients undergoing ATRA/ATO induction regimen.
Trial Details
NCT Number NCT06544109
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions
(from sponsor)		 Acute Promyelocytic Leukemia
Related terms Leukemia, Promyelocytic, Acute
Enrollment 98 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov